This HTML5 document contains 138 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n6http://dx.doi.org/10.1002/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35021812
rdf:type
wikibase:Item
schema:description
2010年论文 article scientifique (publié 2010) vědecký článek mokslinis straipsnis 2010年論文 scientific article 2010年论文 научная статья 2010年の論文 vitskapeleg artikkel מאמר מדעי 2010年论文 artigo científico (publicado na 2010) scienca artikolo บทความทางวิทยาศาสตร์ wissenschaftlicher Artikel videnskabelig artikel (udgivet 2010) vetenskaplig artikel научни чланак 2010年論文 مقالهٔ علمی articol științific 2010年论文 مقالة علمية tudományos cikk vitenskapelig artikkel article scientific artikulong pang-agham tieteellinen artikkeli научна статия artículu científicu espublizáu en 2010 2010 nî lūn-bûn article científic 2010年论文 wetenschappelijk artikel 2010年论文 мақолаи илмӣ 2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված teaduslik artikkel 2010年論文 2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած 2010년 논문 vedecký článok naučni članak სამეცნიერო სტატია artikull shkencor мақолаи илмӣ artykuł naukowy artigo científico (publicado na 2010) bilimsel makale artículo científico publicado en 2010 artigo científico 2010年論文 articolo scientifico научни чланак سائنسی مضمون ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ bài báo khoa học наукова стаття, опублікована у вересні 2010 2010年論文 επιστημονικό άρθρο
p:P577
wds:Q35021812-54B4BED2-FF93-45F3-BCCB-8492E2FE2BBE
wdt:P577
2010-09-01T00:00:00Z
p:P2860
wds:Q35021812-5EA174E4-C174-40FC-8F8D-53D4DCEE785D wds:Q35021812-705890E9-1EF3-40C2-8579-A9016947C616 wds:Q35021812-408F653E-6F34-4ADB-8B4E-014F42FF8CE6 wds:Q35021812-92D64433-03D0-4BCC-9DFA-BE3811E56F40 wds:Q35021812-9F61B4AF-CBF7-4DCF-8A55-2C43596ABA4C wds:Q35021812-735ECFFE-A421-4CFC-B952-926AAAB7B9A6 wds:Q35021812-0EF8408A-A1DB-4439-996B-6DC7DA7F4696 wds:Q35021812-20F0F3C8-E83F-4D28-A18B-4F6DD0619888 wds:Q35021812-22CA2191-B4D3-47AB-BB8B-6A5527D9DD14 wds:Q35021812-153503D5-4E6A-48F0-BADF-9D5753901A2B wds:Q35021812-1B10C381-5159-4979-B01E-885715A7EA75 wds:Q35021812-1DDFF21B-FC52-4361-8CD5-3F78ECA2656A wds:Q35021812-DF0577CF-1E49-4336-BC20-70EA9B664425 wds:Q35021812-F22C349A-11EE-4B55-A8CE-0C71BCE1512A wds:Q35021812-B2FC4688-F0DD-4D66-935A-D593E8709507 wds:Q35021812-CF2F3E7E-834F-4000-A36E-D4C788CBA724
wdt:P2860
wd:Q34369159 wd:Q46229252 wd:Q73565827 wd:Q51790069 wd:Q35550062 wd:Q33911013 wd:Q33379210 wd:Q35638565 wd:Q34327451 wd:Q81922707 wd:Q79402264 wd:Q58659611 wd:Q33975216 wd:Q35469372 wd:Q36655433 wd:Q81364717
p:P2093
wds:Q35021812-30FA035F-CF07-4B55-AF85-BE28304DB8D9 wds:Q35021812-83B0AD37-D450-42D2-A664-837391EC2F35 wds:Q35021812-8DE788E3-1274-44EF-AF34-047D56EC363F wds:Q35021812-9F969B97-344C-47AD-814E-0E054DBE28EE wds:Q35021812-91269FB4-DD9E-4CE7-B1C8-22ECB313697B
wdt:P2093
Ritu Valiyil Andrew Mammen Livia Casciola-Rosen Lisa Christopher-Stine Grace Hong
rdfs:label
Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series
skos:prefLabel
Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series
schema:name
Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series
p:P1476
wds:Q35021812-284B425D-B878-40C8-BE65-F88014F2CA4A
wdt:P1476
Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series
p:P304
wds:Q35021812-04CAB96F-7D06-4FF9-A43A-17B59D45449A
wdt:P304
1328-1334
p:P31
wds:Q35021812-2E8BA8D5-A19C-44C9-9418-BEAA33ED1FE1
wdt:P31
wd:Q13442814
p:P921
wds:Q35021812-C69A3052-B4AD-4DCB-B8D1-58B951789087 wds:Q35021812-E280FDA6-6DAF-4E8E-964F-64B0E04934DC
wdt:P921
wd:Q412323 wd:Q79460
p:P698
wds:Q35021812-4022A609-72E5-4C6A-B1FA-AF4048ED381F
wdtn:P698
n9:20506493
wdt:P698
20506493
p:P1433
wds:Q35021812-6C69C25D-5B9E-49BC-8599-FD22FE1ED134
wdt:P1433
wd:Q15754720
p:P433
wds:Q35021812-7CA47855-F54B-48DB-8C56-DF8A1005CFCE
p:P478
wds:Q35021812-F44C05C3-113A-4682-9FB7-8E42F340CBE6
wdt:P433
9
wdt:P478
62
p:P356
wds:Q35021812-CA8DA818-F1E3-49A8-AE5B-A362571BA819
wdtn:P356
n6:ACR.20219
wdt:P356
10.1002/ACR.20219
p:P5875
wds:Q35021812-1F93AE65-FDCD-41A1-AC01-2B018DBC1F12
wdt:P5875
44634133
p:P932
wds:Q35021812-26FFF6DD-0419-46B5-B31C-0C15423921FE
wdt:P932
3107255